{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:30:57Z","timestamp":1785256257567,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2810-1","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T11:46:50Z","timestamp":1510660010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Mayara Lisboa","family":"Bastos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorrayne Beliqui","family":"Cosme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geisa","family":"Fregona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Nascimento","family":"do Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelmo In\u00e1cio","family":"Bertolde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Zandonade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro N.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareth Pretti","family":"Dalcolmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afr\u00e2nio","family":"Kritski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anete","family":"Trajman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethel Leonor Noia","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"2810_CR1","unstructured":"WHO. Global Tuberculosis Report. 2015. Available: http:\/\/apps.who.int\/iris\/bitstream\/10665\/250441\/1\/9789241565394-eng.pdf?ua=1 . In."},{"issue":"4","key":"2810_CR2","first-page":"382","volume":"14","author":"JA Caminero","year":"2010","unstructured":"Caminero JA. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2010;14(4):382\u201390.","journal-title":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"9","key":"2810_CR3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","volume":"10","author":"JA Caminero","year":"2010","unstructured":"Caminero JA, Sotgiu G, Zumla A, Migliori GB. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis. 2010;10(9):621\u20139.","journal-title":"Lancet Infect Dis"},{"key":"2810_CR4","unstructured":"Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Brasil. Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis. 2015. Rede de Teste R\u00e1pido para Tuberculose no Brasil : primeiro ano da implanta\u00e7\u00e3o. Available: http:\/\/portalarquivos.saude.gov.br\/images\/pdf\/2016\/janeiro\/19\/rtr-tb-15jan16-isbn-web.pdf . In."},{"key":"2810_CR5","unstructured":"Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica. 2011. Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil. Available: http:\/\/portalarquivos.saude.gov.br\/images\/pdf\/2015\/junho\/30\/MANUAL-DE-RECOMENDACOES-PARA-O-CONTROLE-DA-TUBERCULOSE-NO-BRASIL.pdf . In."},{"key":"2810_CR6","doi-asserted-by":"crossref","unstructured":"Bastos ML, Lan Z, Menzies D. An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis. Eur Respir J. 2017;49(3)","DOI":"10.1183\/13993003.00803-2016"},{"issue":"8","key":"2810_CR7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001300","volume":"9","author":"SD Ahuja","year":"2012","unstructured":"Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012;9(8):e1001300.","journal-title":"PLoS Med"},{"issue":"3","key":"2810_CR8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(09)70041-6","volume":"9","author":"EW Orenstein","year":"2009","unstructured":"Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Galvani AP. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. 2009;9(3):153\u201361.","journal-title":"Lancet Infect Dis"},{"key":"2810_CR9","volume-title":"Correlates of treatment outcomes of multidrug-resistant tuberculosis (MDR-TB): a systematic review and meta-analysis. [PhD dissertation]","author":"Y Akcakir","year":"2010","unstructured":"Akcakir Y. Correlates of treatment outcomes of multidrug-resistant tuberculosis (MDR-TB): a systematic review and meta-analysis. [PhD dissertation]. Montreal: Department of Epidemiology & Biostatistics, McGill University; 2010."},{"issue":"9","key":"2810_CR10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006914","volume":"4","author":"JC Johnston","year":"2009","unstructured":"Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2009;4(9):e6914.","journal-title":"PLoS One"},{"key":"2810_CR11","unstructured":"Minist\u00e9rio da Sa\u00fade. Brasil. Sistema de Informa\u00e7\u00e3o de Tratamentos Especiais de Tuberculose. Available: http:\/\/sitetb.saude.gov.br\/download.html . In."},{"issue":"6","key":"2810_CR12","first-page":"640","volume":"9","author":"KF Laserson","year":"2005","unstructured":"Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V, Zarovska E, Rich ML, Fraser HS, Alarcon E, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2005;9(6):640\u20135.","journal-title":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"10","key":"2810_CR13","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/cid\/ciu619","volume":"59","author":"ML Bastos","year":"2014","unstructured":"Bastos ML, Hussain H, Weyer K, Garcia-Garcia L, Leimane V, Leung CC, Narita M, Pena JM, Ponce-de-Leon A, Seung KJ, et al. Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014;59(10):1364\u201374.","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"8","key":"2810_CR14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160109","volume":"11","author":"VC Micheletti","year":"2016","unstructured":"Micheletti VC, Kritski AL, Braga JU. Clinical features and treatment outcomes of patients with drug-resistant and drug-sensitive tuberculosis: a historical cohort study in Porto Alegre, Brazil. PLoS One. 2016;11(8):e0160109.","journal-title":"PLoS One"},{"issue":"3","key":"2810_CR15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5588\/ijtld.12.0537","volume":"17","author":"A Toczek","year":"2013","unstructured":"Toczek A, Cox H, du Cros P, Cooke G, Ford N. Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2013;17(3):299\u2013307.","journal-title":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"3","key":"2810_CR16","volume":"11","author":"J Yin","year":"2016","unstructured":"Yin J, Yuan J, Hu Y, Wei X. Association between directly observed therapy and treatment outcomes in multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0150511.","journal-title":"PLoS One"},{"key":"2810_CR17","unstructured":"WHO. Treatment guidelines for drug-resistant tuberculosis. 2016. Available: http:\/\/apps.who.int\/iris\/bitstream\/10665\/250125\/1\/9789241549639-eng.pdf ."},{"issue":"7","key":"2810_CR18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020436","volume":"6","author":"JE Farley","year":"2011","unstructured":"Farley JE, Ram M, Pan W, Waldman S, Cassell GH, Chaisson RE, Weyer K, Lancaster J, Van der Walt M. Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of south African patients with high HIV prevalence. PLoS One. 2011;6(7):e20436.","journal-title":"PLoS One"},{"issue":"1","key":"2810_CR19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1164\/rccm.200907-0989OC","volume":"181","author":"NR Gandhi","year":"2010","unstructured":"Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 2010;181(1):80\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2810_CR20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3201\/eid1305.060334","volume":"13","author":"CH Haar","year":"2007","unstructured":"Haar CH, Cobelens FG, Kalisvaart NA, van der Have JJ, van Gerven PJ, van Soolingen D. Tuberculosis drug resistance and HIV infection, the Netherlands. Emerg Infect Dis. 2007;13(5):776\u20138.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"2810_CR21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/QAD.0000000000001016","volume":"30","author":"B Karo","year":"2016","unstructured":"Karo B, Krause G, Hollo V, van der Werf MJ, Castell S, Hamouda O, Haas W. Impact of HIV infection on treatment outcome of tuberculosis in Europe. AIDS (London, England). 2016;30(7):1089\u201398.","journal-title":"AIDS (London, England)"},{"issue":"2","key":"2810_CR22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/QAI.0b013e31821190a3","volume":"57","author":"CL Kvasnovsky","year":"2011","unstructured":"Kvasnovsky CL, Cegielski JP, Erasmus R, Siwisa NO, Thomas K, der Walt ML. Extensively drug-resistant TB in eastern cape, South Africa: high mortality in HIV-negative and HIV-positive patients. Journal of acquired immune deficiency syndromes (1999). 2011;57(2):146\u201352.","journal-title":"Journal of acquired immune deficiency syndromes (1999)"},{"issue":"3","key":"2810_CR23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144249","volume":"11","author":"M van der Walt","year":"2016","unstructured":"van der Walt M, Lancaster J, Shean K. Tuberculosis case fatality and other causes of death among multidrug-resistant tuberculosis patients in a high HIV prevalence setting, 2000\u20132008, South Africa. PLoS One. 2016;11(3):e0144249.","journal-title":"PLoS One"},{"issue":"16","key":"2810_CR24","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","volume":"365","author":"FX Blanc","year":"2011","unstructured":"Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, Madec Y, Marcy O, Chan S, Prak N, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365(16):1471\u201381.","journal-title":"N Engl J Med"},{"issue":"6","key":"2810_CR25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1086\/597098","volume":"48","author":"SP Koenig","year":"2009","unstructured":"Koenig SP, Riviere C, Leger P, Joseph P, Severe P, Parker K, Collins S, Lee E, Pape JW, Fitzgerald DW. High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009;48(6):829\u201331.","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"key":"2810_CR26","unstructured":"Baghaei PT, Marjani P, Moniri M, Masjedi A, M R. effect of diabetes mellitus on the time of mycobacterial clearance from sputum during the treatment of multi-drugs resistant tuberculosis. Eur Respir J. 2014;44"},{"issue":"5","key":"2810_CR27","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1513\/AnnalsATS.201312-447OC","volume":"11","author":"K Duraisamy","year":"2014","unstructured":"Duraisamy K, Mrithyunjayan S, Ghosh S, Nair SA, Balakrishnan S, Subramoniapillai J, Oeltmann JE, Moonan PK, Kumar AM. Does alcohol consumption during multidrug-resistant tuberculosis treatment affect outcome?. A population-based study in Kerala, India. Annals of the American Thoracic Society. 2014;11(5):712\u20138.","journal-title":"Annals of the American Thoracic Society"},{"issue":"6","key":"2810_CR28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.5588\/ijtld.14.0811","volume":"19","author":"MJ Magee","year":"2015","unstructured":"Magee MJ, Kempker RR, Kipiani M, Gandhi NR, Darchia L, Tukvadze N, Howards PP, Narayan KM, Blumberg HM. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2015;19(6):685\u201392.","journal-title":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease"},{"key":"2810_CR29","doi-asserted-by":"crossref","unstructured":"Magee MJK, Kipiani RR, Tukvadze M, Howards N, Venkat Narayan PP, Blumberg KM, H M. diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia. PLoS One. 2014;9(4)","DOI":"10.1371\/journal.pone.0094890"},{"key":"2810_CR30","doi-asserted-by":"crossref","unstructured":"Fregona G, Cosme LB, Moreira CMM, Bussular JL, VdV D, Dalcolmo MP, Zandonade E, ELN M. risk factors associated with multidrug-resistant tuberculosis in Esp\u00edrito Santo, Brazil. Rev Saude Publica. 2017;51","DOI":"10.1590\/s1518-8787.2017051006688"},{"issue":"1","key":"2810_CR31","doi-asserted-by":"crossref","first-page":"e15841","DOI":"10.1371\/journal.pone.0015841","volume":"6","author":"JC Brust","year":"2011","unstructured":"Brust JC, Lygizos M, Chaiyachati K, Scott M, van der Merwe TL, Moll AP, Li X, Loveday M, Bamber SA, Lalloo UG, et al. Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela ferry, South Africa. PLoS One. 2011;6(1):e15841.","journal-title":"PLoS One"},{"issue":"9","key":"2810_CR32","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-144-9-200605020-00008","volume":"144","author":"TH Holtz","year":"2006","unstructured":"Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med. 2006;144(9):650\u20139.","journal-title":"Ann Intern Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2810-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T03:47:56Z","timestamp":1570333676000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2810-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2810"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2810-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]},"article-number":"718"}}